IL6 and uveal melanoma: Similarly, IL-6 treatment increased migration in uveal melanoma cells, together with reduced expression of cell adhesion molecules (TJP1, TJP2 and CDH1), and increased levels of focal adhesion molecules (FN1 and ICAM-1) and fibronectin receptor integrin subunits [93].